Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir®

Hormone and Metabolic Research

Volumn 27, Issue 12, 1995, Pages 515-522

  Schmitz, F J ^a   Rosen, R ^a   Reinauer, H ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

carnitine metabolism; CPT l inhibitor; diabetes; Etomoxir ; heart function; lipid metabolism

Indexed keywords

3 HYDROXYBUTYRIC ACID; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CHOLESTEROL; ETOMOXIR; FATTY ACID; GLUCOSE; GLYCEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; HEART FUNCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID OXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0029587279     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-980016     Document Type: Article

References (0)